http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110108888-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-1486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-149 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-14 |
| filingDate | 2019-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110108888-B |
| titleOfInvention | Method for detecting erythrocyte DNA damage signal and application of method in lymphoma prognosis |
| abstract | The invention belongs to the field of medical biology, and relates to an application of erythrocyte DNA damage signals in lymphoma prognosis, which comprises the following steps of S1, preparing a blood sample; s2, cleaning a control group and an experimental group; s3: staining the second experimental group; s4: resuspending the second control group; s5: detecting the third experimental group and the third control group by a flow method; s6: analyzing the result; s7, comparing the change of the DNA damage signal ratio of the patient, simultaneously establishing DNA damage signal databases of healthy people and lymphoma disease people, rapidly and effectively comparing the DNA damage signals of the lymphoma disease patient with the databases, and evaluating the prognosis of the lymphoma disease patient. The method for rapidly judging the DNA damage signal in early damaged red blood cells in lymphoma patients by using trace blood samples and reagents has the advantages of strong specificity and high sensitivity. |
| priorityDate | 2019-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.